Printer Friendly

Articles from The Fly (June 3, 2019)

1-168 out of 168 article(s)
Title Author Type Words
Achieve Life Sciences receives $4.2M from exercise of warrants. 169
Addus HomeCare completes VIP Health Care purchase, says looking for more deals. 235
Alexco Resource announces $6.5M bought deal equity financing. 113
Algonquin Power to acquire Bermuda Electric Light Company for $365M. 116
Altria Group to acquire 80% ownership of certain Burger Group companies. 151
AMD's Radeon Pro Vega II GPUs to be included in new Mac Pro. 138
American Airlines confirms DOT tentative approval of Qantas partnership. 106
American States Water says CPUC approves new water rates. 603
Amgen: 5 patients experienced partial response in AMG 510 Phase 1 study. 385
Ancora Advisors urges J. Alexander's holders to withhold votes at Annual meeting. 172
Apple announces tvOS 13 operating system for Apple TV. 133
Apple announces watchOS 6 operating system for Apple Watch. 133
Apple introduces new Mac Pro, Pro Display XDR. 153
Apple previews iOS 13 with Dark Mode, new camera features, improved maps. 279
Apple previews iPadOS with new home screen, split view, Dark Mode. 192
Apple previews macOS Catalina, replaces iTunes with three apps. 141
Apple unveils new technologies for app development. 168
Ashford to acquire Remington's Hotel Management business for $275M. 127
AstraZeneca, Merck present full Phase 3 SOLO3 trial results at ASCO. 337
AT&T's streaming plans hit snag over price of HBO subscription, NY Times reports. 123
Atlanta Fed GDPNow forecast for real Q2 GDP growth is now at a 1.256% pace. 115
Avenue Therapeutics Phase 3 tramadol study achieves primary, secondary endpoints. Report 308
Big Lots estimates for Q2, FY raised at Raymond James. 101
BioXcel Therapeutics announces FDA clearance of IND for BXCL701 therapy. 254
Bluebird Bio announces EU conditional marketing authorization for ZYNTEGLO. 197
Blueprint Medicines announces new data from ARROW trial of BLU-667. 138
Boeing says one batch of slat tracks found to have a potential nonconformance. 251
Bow Street says Glass Lewis recommends vote for its Mack-Cali nominees. 199
Box reports Q1 adjusted EPS (3c), consensus (5c). Financial report 101
Bristol-Myers updates results from studies evaluating Opdivo. 182
Bristol-Myers' Opdivo+Yervoy HCC study yields 31% ORR. 131
Bullish call spreads in Overstock as shares advance from 52-week lows. 104
Callaway's Tokyo unit acquires remaining 48% stake in Callaway Apparel K.K. 169
Can-Fite says Phase II liver cancer study did not meet primary endpoint. 338
Celgene announces updated analysis of data from Phase 2 JAKARTA2 clinical study. Clinical report 206
Centene weakness due to Humana disclosure 'overdone,' says Cantor Fitzgerald. 119
Cheniere announces Sabine Pass Train 6 final invesment decision. 143
Cheniere Corpus Christi Stage III, Apache sign long-term gas supply agreement. 177
Cheniere Energy expects to generate over $9B available cash through 1H24. 248
Cheniere Energy Partners makes positive final investment decision on Train 6. 140
Compugen presents update on COM701 Phase 1 trial at ASCO. 110
Constellation Pharmaceuticals announces presentation of MANIFEST data at ASCO. 433
Continental Resources announces initial $1B share repurchase program. 159
Credit Suisse names Zhenyi Tang as CEO of China. 167
Customers Bancorp holders approve 'say on pay' proposal at annual meeting. 132
CVS calls lead puts 3:1 as shares display relative strength. 123
Cypress Semiconductor takeout pays off for last week's call buyers. 133
DelMar Pharmaceuticals announces $3.6M registered direct offering. 144
DelMar Pharmaceuticals provides update on VAL-083 studies. 472
Denison Mines begins environmental impact assessment for Wheeler River project. 409
DOJ's Google probe could embolden critics of tech giants, says BofA/Merrill. 165
DOT grants tenative approval for American Airlines-Qantas JV, Reuters reports. 117
Dropbox quietly increased prices by 20%, says Deutsche Bank. 114
DuPont begins regular way trading on NYSE. 122
DuPont initiated with an Overweight at Morgan Stanley. 107
Dynavax reports results from Phase 1b/2 study of SD-101 and Keytruda combination. 206
Edwards Lifesciences urges holders to reject 'mini-tender offer' by TRC Capital. 172
Elixinol says hopes FDA 'takes strikes' in acceptance of hemp-driven CBD. 177
Emergent BioSolutions awarded 10-year contract valued at $535M. 179
Endava announces 2 corporate transactions. 312
EPE to be acquired by Infrastructure Investments Fund for $68.25/share. 159
Epizyme reports new data from Phase 2 Trial of Tazemetostat at ASCO. 235
Euroseas announces refinancing of two vessels, acquisition of four vessels. 331
FAA says some Boeing 737 NG and MAX models contain improper slat tracks. 241
Facebook implied volatility sharply higher as shares come under fire. 141
Fanhua provides update on share buyback program. 136
FDA approves new indication for Merck's Zerbaxa. 161
Fed's Bullard says rate cut 'may be warranted soon'. 108
Fedspeak hasn't broken any new ground on policy. 165
Fiat Chrysler reports May U.S. sales up 2% to 218,702 vehicles. Financial report 133
Fiat Chrysler-Renault deal would increase resources, overseas exposure, WSJ says. 112
Financial firms offer J.C. Penney vendors credit risk protection, NY Post says. 104
Fly Intel: Pre-market Movers. 257
Fly Intel: Top five analyst downgrades. 178
Fly Intel: Top five analyst initiations. 154
Fly Intel: Top five analyst upgrades. 205
Forty Seven announces updated data on 5F9 with azacitidine trial at ASCO. 708
FTC gets jurisdiction to open Facebook antitrust investigation, WSJ reports. 148
FTD Companies files voluntary Chapter 11 petitions. 446
Genentech: POLYP 1, POLYP 2 Phase III trials met co-primary, secondary endpoints. 184
Genentech: POLYP 1, POLYP 2 Phase III trials met co-primary, secondary endpoints. 201
Genocea presents GEN-009 data at ASCO. 120
GM executive implies financing moving forward with Workhorse Group. 117
Goodyear puts active as shares gain traction. 116
Greenbrier appoints Adrian Downes CFO. 101
Gulf Resources temporarily suspends trial production at Sichuan gas well. 280
Heavy volume in Twitter options as antitrust headlines bite FANG names. 103
Hi Ho Call spread in Silver ETF. 116
Hospitality Properties to buy net lease portfolio from Spirit MTA REIT for $2.4B. 205
House panel chairman announces probe into competition in digital markets. 285
House passes $19B disaster aid package, sends it to Trump, CNBC says. 117
Humana confirms it will not propose merger with Centene. 105
IBM launches 'self-service advertising solution' Watson Ads Builder. 222
Infineon to acquire Cypress Semi in deal with enterprise value of EUR9B. 379
IntercontinentalExchange names John Tuttle vice chairman of NYSE Group. 138
Internet Gold receives noncompliance notice from Nasdaq. 144
Ironwood, Allergan initiate dosing in Phase II clinical trial of MD-7246. 119
Kite announces new Yescarta data from ZUMA-1. 577
Kyocera enters collaboration with BYD Japan. 167
LabCorp and Envigo complete previously announced transactions. 171
LabCorp announces new term loan facility. 131
Loop Capital 'enthusiastic' about Green Dot's BaaS platform efforts. 111
Mack-Cali Realty urges holders to vote 'FOR' all nominees on White proxy card. 123
MannKind says Afrezza inhalation powder approved in Brazil. 129
Matson says on schedule to meet IMO 2020 emission regulation. 166
MEI Pharma presents new clinical data on ME-401. 129
Merck confirms FDA approval of Zerbaxa indication. 220
Merck KGaA says tepotinib shows 'durable anti-tumor clinical activity'. 233
Merck's Lynparza study demonstrated 72% ORR in Phase 3 Solo3 trial. 133
Micron price target lowered to $32 from $45 at Nomura Instinet. 130
Mirati Therapeutics jumps after Amgen announces AMG 510 data. 177
Murphy Oil announce close of Gulf acquisition, provides updated production view. 203
Myriad Genetics announces results from myRisk studies to be featured at ASCO. 106
NanoViricides receives favorable FDA comments on lead drug candidate. 122
NantHealth, NantOmics to present TMB data at ASCO. 116
NantKwest launches Phase 1 trial of CD19 t-haNK cell therapy in lymphoma. 151
Natera's Signatera test detects immunotherapy treatment response in new study. 172
Netflix, Russo brothers to create 'Magic: The Gathering' series. 110
Nissan CEO says would review Renault relationship after FCA merger. 115
Novartis to present new data, trial updates in NSCLC at ASCO. 148
Novartis to present new data, trial updates in NSCLC at ASCO. 187
One Stop Systems wins joint design-in from transportation network company. 118
Oppenheimer upgrades Teva, despite legal uncertainty, with stock at 19-year low. 126
Orchard Therapeutics announces offering of 9M ADSs. 127
Outlook Therapeutics signs manufacturing supply agreement with Fujifilm Diosynth. 206
Pebblebrook Hotel to sell Hotel Amarano Burbank for about $72.9M. 134
Piper a buyer of Amgen shares after 'impressive' AMG 510 data. 153
Piper survey shows 'surprisingly high amount of interest' in 5G iPhones. 160
PVH Corp., G-III Apparel enter licensing agreement in U.S, Canada. 110
Quest Diagnostics notified of breach at billing collections vendor. 336
Renault initiated with a Top Pick at RBC Capital. 103
S&P announces changes to S&P 400, 500 indices. 137
Samsung partnership with AMD 'surprising,' says Rosenblatt. 101
Samsung to pay AMD license fees and royalties under new partnership. 188
Scholar Rock announces final top-line results from Phase 1 SRK-015 trial. Financial report 367
Sears Hometown and Outlet to be acquired by Transform Holdco for $2.25 per share. 356
Seattle Genetics announces additional analyses of ECHELON-1, ECHELON-2 trials. 884
Seattle Genetics, Astellas announce data from cohort of EV-201 trial. 516
Seattle Genetics, Astellas Pharma: Enfortumab vedotin rapidly shrank tumors. 164
Sellas Life Sciences announces results from trastuzumab +/- NPS trial at ASCO. Financial report 390
Sientra announces $75M common stock offering. 124
Sierra Metals repurchases royalty at Cusi Silver Mine in Mexico for $4M. 117
Siga Technologies enters promotion agreement with Meridian for TPOXX. 152
Size, timeline of Emergent new contract 'a clear positive,' says Wells Fargo. Chronology 152
SoftBank faces struggles as it seeks to raise second $100B fund, WSJ says. 111
Spirit Realty comments on recent announcement by Spirit MTA REIT. 422
Takeda announces new data from ad-hoc analysis of Phase 3 HELP Study. 207
TransMedics receives PMA approval from FDA for OCS Lung system. 150
Treasury Action: yields got an extra nudge lower. 128
Treasury's $72 B 3- and 6-month bill auctions were poorly subscribed. 242
Tronox announces up to $100M share repurchase program. 103
Trump tweet's AT&T's CNN is 'very bad for U.S.'. 106
TuanChe to acquire Longye for U.S. equivalent of RMB200M. 249
Twitter acquires London-based deep learning firm Fabula AI, terms undisclosed. 189
Ubisoft's Remy says doesn't want 'Rainbow Six Siege' sequel, Daily Star says. 145
Ultra Petroleum backs FY19 production guidance 240-250 Bcfe. 180
United Rentals announces enhanced capital allocation strategy. 147
US Oil Fund puts active as crude oil gives up earlier gains. 162
Vaccinex announces interim results of pepinemab with avelumab study at ASCO. 365
VBL Therapeutics presents final VB-111 trial results at ASCO. 158
VBL Therapeutics presents VB-111 data at ASCO. 184
Ventas announces offering of 11M shares of common stock. 109
Ventas to acquire $1.8B seniors housing portfolio in Quebec in pact with LGM. 136
Verint urges stockholders to vote for all of company's directors. 343
Vical and Brickell Biotech announce merger agreement. 474
Volkswagen plans dual listing for TRATON SE. 236
VW CEO met with USTR as Mexico tariffs loom, Reuters says. 101
W.P. Carey, Extra Space Storage announce self-storage net lease transaction. 150

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |